Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Farmers Insurance

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,872,130

« Back to Dashboard

Details for Patent: 5,872,130

Title: Quinoline type mevalonoactones
Abstract:Described herein are mevalonolactone derivatives having a quinoline ring of formula (I) ##STR1## wherein the R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, Y and Z variables are described therein.
Inventor(s): Fujikawa; Yoshihiro (Funabashi, JP), Suzuki; Mikio (Funabashi, JP), Iwasaki; Hiroshi (Funabashi, JP), Sakashita; Mitsuaki (Shiraoka-machi, JP), Kitahara; Masaki (Shiraoka-machi, JP)
Assignee: Nissan Chemical Industries Ltd. (Tokyo, JP)
Filing Date:Dec 19, 1990
Application Number:07/631,092
Claims:1. A compound of the formula ##STR16## wherein c-Pr is cyclopropyl, and Z is --CH(OH)--CH.sub.2 --CH(OH)--CH.sub.2 --COOH, --CH(OH)--CH.sub.2 -- CH(OH)--CH.sub.2 --COONa, --CH(OH)--CH.sub.2 --CH(OH)--CH.sub.2 --COOR (wherein R is C.sub.1-3 alkyl), or ##STR17##

2. An anti-hyperlipidemia agent containing the compound of the formula A as defined in claim 1.

3. An anti-hyperlipoproteinemia agent containing the compound of the formula A as defined in claim 1.

4. An anti-atherosclerosis agent containing the compound of the formula A as defined in claim 1.

5. A method for reducing hyperlipidemia, hyperlipoproteinemia or atherosclerosis, which comprises administering an effective amount of the compound of formula A as defined in claim 1.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Fish and Richardson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus